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Abstract: Cancer is a deadly disease that has devastated many lives over the years. Cancer, 
when detected in the early stage, can be cured through proper treatment, increasing the life 
expectancy of the patient. Thus, it is very important to detect cancer at the early stage. The 
current method of cancer detection is biopsy which is a total invasive medical procedure. 
Owing to the several limitations of the time-consuming procedure of biopsy researchers and 
scientist all over the globe have turned their attention towards the development of 
instruments for rapid and non-invasive detection of cancer through detection of clinically 
recognized cancer biomarkers present in blood and other body fluid of cancer patients. This 
paper discusses some of the novel biomarkers used for cancer diagnosis along with the 
potential use of biosensors in early detection of cancer. 
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1. Introduction 
 
Cancer is a deadly disease responsible for many 
deaths over the years. More than 575,000 people 
die of cancer, and 1.5 million people are diagnosed 
with cancer per year only in the U.S. [1]. Cancer is 
caused due to uncontrolled cell growth. There are 
over 100 types of different cancers arising in 
different parts of the body [2]. Some of the 
common cancers are Kidney, Liver, Ovarian, 
Colon, Stomach etc. The exact cause of cancer is 
yet to be known to medical science. It is believed 
that cancer risk can be reduced by avoiding 
tobacco, limiting alcohol intake, limiting exposure 
to UV rays from the sun and maintaining a regular 
healthy diet. According to the World Health 
Organization, (WHO), the number of new cases is 
expected to rise by 70% over the next 20 years [3]. 
Tumor is mainly are of two types: Benign and 
Malignant. A benign tumor is less harmful and can 
be removed through surgery whereas malignant 
tumors are aggressive and decrease the life 
expectancy of the patient. A tumor when 
metastasized becomes cancer and spread from one 
organ to another throughout the body through 
blood. Such cancers are responsible for the 
majority of deaths around the world. Thus, early 
detection of cancer is of utmost importance. The 
current method of detection of cancer is biopsy 
which is an invasive process. A Biopsy is a medical 
procedure which requires the insertion of medical 
instruments in the patient’s body for removal of 
certain tissues to be examined to find the presence 
of cancer cells. Such a process is time-consuming 
and further has many limitations. Patients 
undergoing biopsy complains of weak health, 
nausea, insomnia etc. with further post-biopsy 
effects. Thus, the need for non-invasive detection 
has come into importance in the modern time. In 
addition, the need of rapid detection is of utmost 
importance to give immediate results to the patients 
so that their treatment can be started without 
wasting any time. Thus, this need for rapid non-
invasive detection of cancer has led the researchers 
to develop instruments which would detect cancer 
early without the need of an invasive procedure. 
This has led to the development of biosensors for 
non-invasive rapid early detection of cancer.  
 
2. Cancer Biomarkers 
 
Due to several disadvantages of invasive procedure 
of cancer detection researchers and scientist from 
all over the globe have turned their attention 
towards non-invasive diagnosis of cancer using 
Cancer Biomarkers. According to the National 
Cancer Institute, a biomarker is a biological 
molecule found in blood, other body fluids, or 
tissues that is a sign of normal or abnormal process 
of a condition or disease such as cancer [4]. 
Biomarkers may be proteins, nucleic acids or 
peptides. In medicine however, cancer biomarkers 
are limited to proteins only. The presence of 
biomarkers in blood or any other body fluids 
confirms the presence of cancer cells in the body. 
There are different biomarkers for different types 
of cancers. For example, the biomarkers CYFRA 
(Cytokeratin19fragments), CEA 
(Carcinoembryonic antigen), EGFR (epidermal 
growth factor response), SCC (squamous cell 
carcinoma antigen are used for detection of lung 
cancer [5]. Biomarkers MUC-1(CA27.29 and CA 
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15-3) and carcinoembryonic antigen are the two 
biomarkers that are approved by the Food and Drug 
Administration (FDA) for monitoring and 
treatment of the advanced or recurrence breast 
cancer [6]. Biomarkers such as CA-125, CA 72-4 
have been clinically used for ovarian cancer [7]. 
Biomarker CA 19-9 has been clinically used to 
detect Pancreatic Cancer [8]. Alpha-fetoprotein 
biomarker is widely used for detection of 
hepatocellular carcinoma (HCC) [9]. Prostate 
Specific Antigen (PSA) is the most widely used 
biomarker for prostate cancer [10]. High levels of 
CEA, mutated KRAS, TP53, APC are recognized 
biomarkers for colorectal cancer [11]. Carbonic 
anhydrase IX (CA-IX) biomarker is used to Renal 
Cell Carcinoma [12]. The recognized biomarkers 
for oral cancer are IL-8, IL-1-β and S100P [13].  
High levels of epidermal growth factor receptor 
(EGFR) alongwith expression of 0-6 
methylguanine-DNA methyltransferase (MGMT) 
have been clinically used as a biomarker for 
malignant brain cancer (gliblastomas) [14]. 
Mutation of oncogenes such as FLT3, KIT are 
considered as biomarkers for acute leukemia [15]. 
Human papillomavirus (HPV) is the single most 
important etiological agent in cervical cancer, 
contributing to neoplastic progression through the 
action of viral oncoproteins, mainly E6 and E7 
[16]. Classic biomarkers for gastric cancer 
diagnosis include carcinoembryonic antigen and 
cancer antigen 19-9, while microRNA and DNA 
hypomethylation are proposed as novel biomarkers 
[17]. RASSF1A methylation has been considered 
as a biomarker in melanoma (skin cancer) patients 
[18]. In the modern era the two disciplines of 
proteomics and genomics have helped the 
researchers to identify novel biomarkers for cancer 
detection [19]. Today different biomarkers have 
been used clinically for screening, diagnosis and 
monitoring for different cancers. Biomarkers are 
found in different quantities in blood, saliva and 
other body fluids [20]. Biomarkers have been 
recognized as a novel approach for early cancer 
detection.  
 
3. Biosensors 
 
Owing to the non-invasive early detection of cancer 
researchers over the globe have started to design 
and develop biosensors that could detect cancer 
efficiently. Biosensors are devices that are designed 
to detect a specific biological analyte by essentially 
converting a biological entity (protein, DNA, 
RNA) into an electrical signal that can be detected 
and analyzed [21]. Since the sensor senses 
biological materials the word “Bio” comes into 
play. The biological material can be enzymes, 
antibodies, micro-organisms, nucleic acids etc. 
Prof. Leland C. Clark Jr. is known as the “father of 
biosensors” and the modern day glucose sensor is 
based on his research [22]. The three most 
important elements of a biosensor are a biological 
recognition element, a transducer and a signal 
processing system [23]. The biological element 
must be highly specific, stable and immobilized. 
Based on the biological recognition element 
biosensors are classified into the following 
categories: enzymatic, protein, receptor based, 
DNA and whole cell biosensors [24]. The 
transducer converts recognition signal events into 
electrical signals. Based on the signal transduction 
mechanism biosensors are further classified into 
the following categories: Electrochemical, 
Thermal, Optical and Mass Sensitive Sensors [25].  
Electrochemical transducers are the most widely 
used in sensor technology but however, optical 
transducers are gaining importance in the modern 
era due to their several advantages. Signals from 
the transducer are passed to an electronic system 
for amplification and display. 
 
4. Biosensors for Cancer Marker 
Detection 
 
Researchers and scientist are trying to design and 
develop biosensors for detecting cancer markers to 
detect early cancer. The use of biosensors for 
protein biomarker analysis has been developed as 
an attractive and cost effective technique for the 
development of point of care devices [26].  
Electrochemical biosensors have played a 
significant role in cancer marker detection [27]. 
Sensors based on spectroscopy of surface 
plasmons, sometimes referred to as surface 
plasmons resonance sensors (SPR) are being used 
for label free detection of cancer markers [28]. 
Piezoelectric biosensors have also been exploited 
for cancer marker detection due to their light 
weight, high sensitivity and low power requirement 
[29]. W. Tan et al. [30] have developed a surfaced 
immobilized optical protein sensor to detect an IL-
8 marker for oral cancer detection. J. Yuan et al. 
[31] have developed an SPR based biosensor for 
the detection of cancer markers in ovarian cancer. 
T. Kumeria et al. [32] have developed a microchip 
biosensor based on nanoporous aluminia for 
detection of circulating tumor cells. A. Malima et 
al. [33] have developed a highly sensitive 
microscale in-vivo sensor enabled by the 
electrophoretic assembly of nano particles for 
multiple biomarker detections. Optical Biosensors 
are gaining importance in the modern era for 
detection of biomarkers due to its high sensitivity, 
specificity, small size, rapid and cost effectiveness 
[34]. High multi disciplinary approaches like 
nanotechnology, MEMS (micro electro mechnaical 
systems), NEMS, biotechnology etc have been 
used in the implementation of new optical 
biosensors. 
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5. Conclusion 
 
Due to the several limitations in conventional 
detection techniques of cancer researchers and 
scientist are turning their attention towards the 
development of biosensors for efficient rapid non-
invasive detection of cancer markers. Cancer 
markers confirm the presence of cancer cells in the 
body. These markers are present in blood, saliva or 
any other body fluids. Novel biomarkers for 
different cancers are still in the process of research, 
although a few of them have been clinically used 
for screening and monitoring of cancer patients. 
The development of biosensors paves a new novel 
approach for rapid early detection of cancer. 
Different biosensors have been designed by 
researchers for efficient of the cancer markers. 
Optical biosensors are gaining importance over 
other biosensors due to its several advantages. 
However, the development of biosensors for 
multiple cancer marker detection is still a big 
challenge to the scientist and researchers. 
Integration of high multi disciplinary approaches 
along with the use of nanomaterials in development 
of biosensors will enhance the sensitivity of these 
devices and make it more efficient for early 
detection of cancer which is the need of the hour.   
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